More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans
Two Reports Show Progress in Treatment Options for Chronic Disease
WASHINGTON, D.C. (March 20, 2013) – America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditions affecting seniors, according to a new report and overview released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
With the population of Americans over 65 on the rise and life expectancy climbing, chronic diseases remain a principal threat to the health and productivity of older Americans, as well as to rising health care costs. Innovative medicines have led to major advances against many chronic diseases – and the robust discovery pipeline of new medicines portends continued progress for seniors and our health care system.
- 142 for diabetes, which affects 10.9 million Americans age 65 and older;
- 92 for rheumatoid arthritis and osteoarthritis, which affect 1.3 million Americans and 12.4 million people over age 65, respectively;
- 82 for Alzheimer’s disease, which could afflict nearly 8 million people in the U.S. by 2030 unless a treatment or preventative measure is found;
- 48 for heart failure (affecting 5.8 million Americans) and ischemic heart disease; and
- 40 for chronic obstructive pulmonary disease, which impacts more than 13 million adults, with the highest prevalence rate in those over age 65.
- A treatment that aims to prevent or reverse progression of Alzheimer’s disease by using a human monoclonal antibody specifically designed to draw beta amyloid protein away from the brain through the blood system.
- A medication that combines two long-acting drugs, allowing for once-daily dosing in COPD.
- A potential first-in-class medicine to treat type 2 diabetes that increases insulin secretion without causing insulin to significantly lower blood sugar.
- A medicine that recruits a patients’ own neural stem cells to repair or protect against damage to the central nervous system from stress hormones, which can lead to depression.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested over $500 billion in the search for new treatments and cures, including an estimated $49.5 billion in 2011 alone.
Find PhRMA Online:
- Website – http://www.phrma.org
- Facebook – www.facebook.com/PhRMA
- Blog – www.phrma.org/catalyst
- Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress
- YouTube – www.youtube.com/PhRMApress
For information on how innovative medicines save lives, visit: http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org
For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org